Apathy -- a lack of interest or motivation -- could predict the onset of some forms of dementia many years before symptoms start, offering a 'window of opportunity' to treat the disease at an early ...

Older adults who show signs of apathy tend to have a smaller brain volume than their peers with more vim and vigor, a new study suggests. Researchers found that of more than 4,300 older adults, those ...

Employee apathy is often overlooked since those who exhibit this characteristic tend to fly under the radar, which is exactly their goal: to get paid, not bother with anyone unless necessary and not ...

With regard to apathy, the famous Uruguayan writer Mario Benedetti wrote in The Truce: The Diary of Martín Santomé: "I have the terrible feeling that time goes by and I do nothing, nothing happens, ...

Microsoft has disappointed investors with both Copilot and Azure trends recently. Cloud capacity should ultimately increase, ...

Many politicians these days find electoral success in channeling voters’ real or imagined fear. And this time around, the stakes feel like they couldn’t be higher. But after years of growing financial ...

This is apathy. It is aptly stated that apathy is a disease that numbs the soul and dulls the mind. Apathy, often characterised by an absence of interest, enthusiasm, or concern, has the power to ...

Apathy is an early marker of frontotemporal dementia (FTD) and predicts future cognitive decline, a new study has shown. Results showed that apathy occurs early in the disease course of genetic FTD ...

Apathy is the most common neuropsychiatric symptom of dementia, with a bigger impact on function than memory loss -- yet it is under-researched and often forgotten in care. Apathy is the most common ...

Recent studies about Alzheimer’s have focused on risk factors associated with the disease and how consumers can potentially protect themselves from cognitive decline. Now, a new study conducted by ...

Treatment with the antidepressant bupropion does not improve apathy in nondepressed patients with dementia of Alzheimer type (DAT), results of a multicenter, double-blind, placebo-controlled trial ...